Episode 385 -- Five Strategies to Mitigate a New Risk Environment
The Informed Board Podcast | Board Oversight at a Time of Political and Geopolitical Uncertainty
Hot Topics in international Trade - Deep Thoughts with Bob Brewer, VP Marketing, Braumiller Law Group
Hot Topics in International Trade - Evolution of Classification
Navigating U.S.-China Relations: Lessons From History for Today’s Global Economy
Hot Topics in International Trade - Update on Tariffs with Bramiller Law Group Attorney Brandon French
Hot Topics in International Trade - What it means to believe
Hot Topics in International Trade - Tariff Mitigation Strategies with Braumiller Law Group Managing Partner Adrienne Braumiller
Hot Topics in International Trade - Wood Chucks Chuck Canadian Lumber tariffs
State AG Pulse | An Early Peek At the 2026 State AG Elections
From the Editor’s Desk: Compliance Week’s Insights and Reflections from July to August 2025
All Things Investigations – Navigating Secondary Tariffs with Mike Huneke and Brent Carlson
The Presumption of Innocence Podcast: Episode 66 - Tariff Uncertainty and Compliance Risks for Businesses
FCPA Compliance Report: The Impact of Secondary Tariffs on Global Trade with Mike Huneke and Brent Carlson
Impacts of the One Big Beautiful Bill Act on the Agriculture and Food Industry
Regulatory Ramblings: Episode 73 - Geopolitical Risk: Thai Tensions / Sanctions, Tariffs & FCPA Enforcement in Asia
GILTI Conscience Podcast | Beyond the Runway: Navigating Tax, Tariffs and Transfer Pricing in Luxury Fashion
Daily Compliance News: July 9, 2025, The TACO Don Caves Again Edition
How International Companies Can Prepare for July 9 Tariffs
Episode 372 -- DOJ Applies False Claims Act to Tariff and Trade Violations
This edition of the Bermuda Public Companies Update summarises significant transactions involving Bermuda companies listed on the New York Stock Exchange (NYSE) and Nasdaq in the first half of 2025. The first half of 2025...more
Under the terms of a deal with the DOJ announced this week, JPMorgan will pay $920 million and sign on to a deferred prosecution agreement “to resolve charges that it had manipulated markets for U.S. government bonds and...more
Opioid manufacturer Insys Therapeutics, which just last week agreed to pay $225 million to “settle a federal investigation into the marketing practices for its powerful fentanyl painkiller,” has filed for bankruptcy...more